Molecular mechanisms and clinical applications of angiogenesis - sprookjes - yvandenbroek - TriplyDB

Molecular mechanisms and clinical applications of angiogenesis

Molecular mechanisms and clinical applications of angiogenesis

http://www.wikidata.org/entity/Q29547314

about

Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agent Identification of PDCL3 as a novel chaperone protein involved in the generation of functional VEGF receptor 2 CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest.Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis MicroRNA 329 suppresses angiogenesis by targeting CD146 The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis The Role of RhoJ in Endothelial Cell Biology and Tumor Pathology Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance KSHV-Mediated Angiogenesis in Tumor Progression Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics Molecular Imaging of Angiogenesis and Vascular Remodeling in Cardiovascular Pathology Modulation of Host Angiogenesis as a Microbial Survival Strategy and Therapeutic Target Therapy Effects of Bone Marrow Stromal Cells on Ischemic Stroke Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases Regenerative Applications Using Tooth Derived Stem Cells in Other Than Tooth Regeneration: A Literature Review The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology Angiocrine functions of organ-specific endothelial cells p73: a Positive or Negative Regulator of Angiogenesis, or Both?Chemoprevention of Breast Cancer by Dietary Polyphenols The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development Advancing biomedical imaging Role of platelet-rich plasma in ischemic heart disease: An update on the latest evidence Angiomodulatory properties of Rhodiola spp. and other natural antioxidants Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities Non-muscle myosin II in disease: mechanisms and therapeutic opportunities The influence of platelet-derived products on angiogenesis and tissue repair: a concise update Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization Type-2 pericytes participate in normal and tumoral angiogenesis In Vivo pO2 Imaging of Tumors: Oxymetry with Very Low-Frequency Electron Paramagnetic Resonance Targeting BMP signalling in cardiovascular disease and anaemia Thymidine Phosphorylase in Cancer; Enemy or Friend?Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation Cancer imaging by optical coherence tomography: preclinical progress and clinical potential.Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis Wounds that will not heal: pervasive cellular reprogramming in cancer Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads Osteoarthritis year 2011 in review: biology Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease

P2860

Q21145736-CDF5E28F-0E8D-4FE8-9302-E3AF1B76B596 Q24296686-B1823F6C-4B95-4A67-9F22-89E4EB1C8EBB Q24306296-B9355205-0A97-47B8-8530-C5774AF3D567 Q24307624-685E958F-0017-49CA-8392-88197B20FB87 Q24310981-B1F565E1-CD6C-41B8-9CDA-B025DCC0F1C9 Q24339531-9D01C2F6-9C91-4B96-97D8-CCA04B54944A Q26739169-6149A369-893C-4CF7-BB53-38F515C4B28D Q26739831-737E405D-0D8F-4A2C-AE24-12A67CE68660 Q26742030-E418C4EC-73FF-4C13-A88B-14AD5C2C6B64 Q26746067-A5C8422C-12EF-46E5-9D81-7CB1A25F3CEB Q26747500-E3ED31C1-3005-480C-B3DA-0DB0863F40F9 Q26748251-59F64C0D-8F7D-4759-9120-B18489F3D236 Q26749052-02C5B80F-ED2C-4224-BB03-0A0DC92A2830 Q26752617-6B517E06-2312-4478-962F-A9F13FE53FBA Q26769983-148D8033-75A8-4D0A-9343-A072D4E37442 Q26770132-783A78AF-355D-4732-AE44-7700691686DC Q26770620-F2FA0E3B-6AB1-4190-8B4A-62C2E0AE4D79 Q26771853-86B2DB27-8A2B-497F-9CD1-C099492F8A86 Q26773449-7868AFE5-14DA-4C08-8038-EA79E6751455 Q26773466-FEB58B7F-133D-434C-B89D-854A9DE87194 Q26776383-EBCBC807-1D7B-48A7-92A6-E7236F221366 Q26777855-3DA2FE3C-8FCE-40AC-BF1A-FF0499149467 Q26777977-B53E8364-D663-4019-A1E6-D8196EA3E619 Q26778344-9A1DE8AF-A5BC-4EE3-8DAC-6526A74C7F76 Q26778962-DB72192B-B49C-4597-BA4C-32767DF51C68 Q26779664-F01C6BF9-D633-43DF-B39E-AAE0B56A2214 Q26781833-D4442A96-2709-4E02-BE85-6C3A3221A5E5 Q26782015-0FD09DBE-B481-489D-93CC-F062D720BEF7 Q26782107-F5C02C51-EE6F-48B6-84B9-B3CA9FADC8D1 Q26783734-D845A4A1-245E-461E-A050-F46705E9F3B1 Q26795650-C9062DE6-CC16-4915-914C-4C446444B08A Q26796395-0C43D8FD-19A3-473A-92D1-D98E7E4EAF3C Q26799437-91B982EE-F759-4468-A195-8B557404016C Q26823084-973D38BC-8E05-4B0A-B530-D0B1BD935AD1 Q26823757-D0AC31CE-7A55-41CB-9F28-82B78258C4E4 Q26826639-AE4C9674-CF25-4123-B630-B0DE4EBA1368 Q26828560-6F4E2776-1663-4C35-8C8A-C92428E99776 Q26830075-56484963-0173-4335-84BE-B23F826E1C18 Q26853546-F8C488B0-2F7F-4ED6-87CA-0ED3D2A32A2E Q26859449-0CD53EC1-B45D-45CF-B224-CAF26676DBCF

P2860

Molecular mechanisms and clinical applications of angiogenesis

http://www.wikidata.org/entity/Q29547314

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Molecular mechanisms and clinical applications of angiogenesis

@ast

Molecular mechanisms and clinical applications of angiogenesis

@en

type

label

Molecular mechanisms and clinical applications of angiogenesis

@ast

Molecular mechanisms and clinical applications of angiogenesis

@en

prefLabel

Molecular mechanisms and clinical applications of angiogenesis

@ast

Molecular mechanisms and clinical applications of angiogenesis

@en

P1433

Q29547314-BBDE8886-6867-4D42-8596-D416A54FDDD8

P1476

Q29547314-F678DF6A-6C46-41AC-8ACB-B93DD4366270

P2093

Q29547314-147CFAF3-989E-4669-A9CD-630D39CE272E

Q29547314-E87C3A62-82F5-44A5-B555-E43D4E1A1DFF

P2860

Q29547314-0014CE82-F7A2-430B-BBBA-74A55B459170

Q29547314-00A70C9B-A19B-410A-B410-698CB79FB8F2

Q29547314-03DAF832-96DD-47BC-8046-688D2D0E65A4

Q29547314-04A5094F-F46D-4E77-BE26-C13459FC681A

Q29547314-061A3731-DFC5-4D4B-8340-8E1DB45B6A7F

Q29547314-0A990B66-9D46-4A6C-A684-D86984190E87

Q29547314-0C90D075-4BF1-4D2F-BE21-C65C3D5C048B

Q29547314-0EAB3A60-DE26-4887-9A68-355725CD7E2F

Q29547314-0F665D4E-C759-4F3B-9EA2-7D38EB07E4CD

Q29547314-127D4F2C-0A9F-4C06-A9AC-E3D0F1860083

P2888

Q29547314-AF43D198-4DC0-4297-942E-F5854472C95E

P304

Q29547314-5CFBB7C6-0C73-4F1A-84F7-FA67676A367A

P31

Q29547314-D5980AE5-89EF-457E-94C1-F11E06BB1DA5

P3181

Q29547314-148A9E1E-63C2-4482-8FE5-6E8F5983EE55

P356

Q29547314-30AAC788-1782-4773-8229-4F9F9C0A8D75

P407

Q29547314-E6E2199A-A13A-45E0-B0EF-66AEA37E7C5B

P433

Q29547314-D1215578-3F5F-46C2-8147-29D87DF8AF98

P478

Q29547314-FE5E48CD-626E-4611-8C1F-5E9487559111

P577

Q29547314-7B671633-D8AD-4232-925A-F33BEFC7CE89

P5875

Q29547314-95360FE1-9B98-4034-B654-A0B1A6621C7D

P6179

Q29547314-A082895F-71B7-43C7-9686-1E05BBC4A351

P698

Q29547314-274392DD-14C1-4372-A7CB-B792D5E0BE48

P921

Q29547314-06ecde6c-47b0-fbb1-0800-d3c68c836729

P932

Q29547314-47E97BC8-9927-47CF-8785-F70816A3FEB3

P3181

P356

P1433

P1476

Molecular mechanisms and clinical applications of angiogenesis

@en

P2093

Carmeliet P

http://www.w3.org/2001/XMLSchema#string

Jain RK

http://www.w3.org/2001/XMLSchema#string

P2860

Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis

Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage

Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization

Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Modes of resistance to anti-angiogenic therapy

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Hypoxia-inducible factors and the response to hypoxic stress

P2888

P304

298-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

255726

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE10144

http://www.w3.org/2001/XMLSchema#string

P407

P433

7347

http://www.w3.org/2001/XMLSchema#string

P478

473

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51147859

http://www.w3.org/2001/XMLSchema#string

P6179

1050798018

http://www.w3.org/2001/XMLSchema#string

P698

21593862

http://www.w3.org/2001/XMLSchema#string

P921

P932

4049445

http://www.w3.org/2001/XMLSchema#string